219
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Efficacy and Safety of Mycophenolate Mofetil in the Treatment of Recalcitrant Intermediate Uveitis

, MS, , MD, FAICO & , MS, FMRF, FNAMS, FIC Path, FAICO
Pages 851-857 | Received 21 Apr 2017, Accepted 14 Mar 2018, Published online: 13 Apr 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Eileen L. Chang & Lucia Sobrin. (2023) Local versus Systemic Therapy for Noninfectious Uveitis (NIU). Seminars in Ophthalmology 38:1, pages 15-23.
Read now

Articles from other publishers (4)

Janet L. Davis. 2022. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology 4161 4191 .
N. Stolowy, E. Zanin, A. Comet, A.-L. Jurquet, C. Benso, F. Matonti, K. Retornaz, G. Kaplanski & D. Denis. (2021) Les immunosuppresseurs dans les uvéites pédiatriques sévères ou chroniques : revue de la littérature. Journal Français d'Ophtalmologie 44:2, pages 252-258.
Crossref
Ahmed Mahjoub, Feriel Ammar, Nadia Ben Abdesslam, Tasnim Mhamdi, Leila Knani, Mohamed Ghorbel & Hachmi Mahjoub. (2020) Retinal vasoproliferative tumor in intermediate uveitis: A case report. Annals of Medicine and Surgery 59, pages 278-280.
Crossref
Janet L. Davis. 2020. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology 1 32 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.